Search Results - Hall-Murray, Cassandra

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults

    Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults by Suaya, José A., Jiang, Qin, Scott, Daniel A., Gruber, William C., Webber, Chris, Schmoele-Thoma, Beate, Hall-Murray, Cassandra K., Jodar, Luis, Isturiz, Raul E.

    Published in Vaccine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population

    Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population by Esposito, Daina, Titievsky, Lina, Beachler, Daniel C., Hawes, Jennifer C.L., Isturiz, Raul, Scott, Daniel A., Gangemi, Kelsey, Maroko, Robert, Hall-Murray, Cassandra K., Lanes, Stephan

    Published in Vaccine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Multicountry Review of Streptococcus pneumoniae Serotype Distribution Among Adults With Community-Acquired Pneumonia

    Multicountry Review of Streptococcus pneumoniae Serotype Distribution Among Adults With Community-Acquired Pneumonia by Grant, Lindsay R, Begier, Elizabeth, Theilacker, Christian, Barry, Rachid, Hall-Murray, Cassandra, Yan, Qi, Pope, Veneta, Pride, Michael W, Jodar, Luis, Gessner, Bradford D

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Is a Consensus Case Definition for Viral Associated Lower Respiratory Tract Disease (LRTD) in Clinical Trials Possible?

    Is a Consensus Case Definition for Viral Associated Lower Respiratory Tract Disease (LRTD) in Clinical Trials Possible? by Williams, S Elizabeth, Gessner, Bradford, Begier, Elizabeth, Aliabadi, Negar, Ilangovan, Kumar, Jodar, Luis, Hall-Murray, Cassandra, Lisi, Giovanni Checcucci, Walsh, Edward

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    1384. Conceptual Economic Model Methodology for Infant Pneumococcal Conjugate Vaccine Program and its Impact on Antimicrobial Resistance

    1384. Conceptual Economic Model Methodology for Infant Pneumococcal Conjugate Vaccine Program and its Impact on Antimicrobial Resistance by Farkouh, Raymond, Nevo, Arianna, Uyei, Jennifer, Althouse, Benjamin, Hall-Murray, Cassandra, Lewnard, Joseph, Wasserman, Matthew

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Sequential Administration of PCV13 Followed by PPSV23 Results in a More Robust Immune Response in PPSV23-Naïve Adults Age 60–64 Years

    Sequential Administration of PCV13 Followed by PPSV23 Results in a More Robust Immune Response in PPSV23-Naïve Adults Age 60–64 Years by Chilson, Erica, Atkinson, Bruce, Hall-Murray, Cassandra, Snow, Vincenza, Schmoele-Thoma, Beate, Isturiz, Raúl E, Scott, Daniel A

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Comment on: “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”

    Comment on: “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japan... by Farkouh, Raymond A., Hall-Murray, Cassandra, Klok, Rogier M., Hilton, Betsy, Isturiz, Raul E.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: